Genome-wide identification of methylated CpG sites in nongenital cutaneous warts

5Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Low-risk HPV infection has not been the subject of epigenetic investigation. The present study was carried out in order to investigate the methylation status of CpG sites in non-genital cutaneous warts. Methods: Genomic DNA was extracted from 24 paired epidermal samples of warts and normal skin. DNA samples were bisulfite converted and underwent genome-wide methylation profiling using the Infinium MethylationEPIC BeadChip Kit. Results: From a total of 844,234 CpG sites, 56,960 and 43,040 CpG sites were found to be hypo- and hypermethylated, respectively, in non-genital cutaneous warts. The most differentially methylated CpG sites in warts were located within the C10orf26, FAM83H-AS1, ZNF644, LINC00702, GSAP, STAT5A, HDAC4, NCALD, and EXOC4 genes. Conclusion: Non-genital cutaneous warts exhibit a unique CpG methylation signature.

Cite

CITATION STYLE

APA

Al-Eitan, L. N., Alghamdi, M. A., Tarkhan, A. H., & Al-Qarqaz, F. A. (2020). Genome-wide identification of methylated CpG sites in nongenital cutaneous warts. BMC Medical Genomics, 13(1). https://doi.org/10.1186/s12920-020-00745-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free